Learnings from the 2024 Utah Cardiac Recovery Symposium: A Roadmap for the Field of Myocardial Recovery

Muthu Kumar Krishnamoorthi, Konstantinos Sideris, Arvind Bhimaraj, Stavros G. Drakos

Research output: Contribution to journalReview articlepeer-review

Abstract

The 12th annual Utah Cardiac Recovery Symposium (U-CARS) in 2024 continued its mission to advance cardiac recovery by uniting experts across various fields. The symposium featured key presentations on cutting-edge topics such as CRISPR gene editing for heart failure, guideline-directed medical therapy for heart failure (HF) with improved/recovered ejection fraction (HFimpEF), the role of extracorporeal cardiopulmonary resuscitation (ECPR) in treating cardiac arrest, and others. Discussions explored genetic and metabolic contributions to HF, emphasized the importance of maintaining pharmacotherapy in HFimpEF to prevent relapse, and identified future research directions including refining ECPR protocols, optimizing patient selection, and leveraging genetic insights to enhance therapeutic strategies.

Original languageEnglish (US)
Pages (from-to)88-97
Number of pages10
JournalMethodist DeBakey cardiovascular journal
Volume20
Issue number4
DOIs
StatePublished - Aug 20 2024

Keywords

  • cardiac recovery
  • cardiomyocytes
  • conference proceedings
  • genetic regulation
  • heart failure
  • MCS
  • metabolism
  • non-cardiomyocyte
  • U-CARS
  • Ventricular Function, Left
  • Humans
  • Cardiopulmonary Resuscitation/methods
  • Treatment Outcome
  • Heart Arrest/therapy
  • Gene Editing
  • Recovery of Function
  • Utah
  • Stroke Volume
  • Heart Failure/physiopathology
  • Animals
  • Extracorporeal Membrane Oxygenation

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Learnings from the 2024 Utah Cardiac Recovery Symposium: A Roadmap for the Field of Myocardial Recovery'. Together they form a unique fingerprint.

Cite this